Athira Pharma, Inc. (NASDAQ: ATHA) reported Q1 EPS of ($0.19), $0.46 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $51.43 million versus the consensus estimate of $0 .

For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.